Therefore, increasing the expression of CUL3 while using SHH activators could not only play an anti-apoptotic and anti-oxidative role in the SHH pathway, but also reduce the level of excessive proliferation and migration of VSMCs, thereby hindering the development of hypertension. The gene discussed is CUL3; the disease is Hypertension.